Furthermore, endogenous cancer-associated fibroblast S100A4 functions to induce resistance to chemotherapeutic agents through myofibroblast transdifferentiation and resultant stiffening of the tumor stromal matrix (85). This evidence concerns the gene S100A4 and cancer.